Molecular epidemiology of clostridium difficile over the course of 10 years in a tertiary care hospital

Clinical Infectious Diseases

Volumn 49, Issue 8, 2009, Pages 1141-1147

  Belmares, Jaime ^a,i   Johnson, Stuart ^a,b,c   Parada, Jorge P ^a,b   Olson, Mary M ^f   Clabots, Connie R ^g   Bettin, Kristine M ^h   Peterson, Lance R ^d,e   Gerding, Dale N ^a,c  

^a Division of Infectious Diseases   (United States)

^b Medical Service   (Spain)

^c HINES VA HOSPITAL   (United States)

^d NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f Infection Control NHS Calderdale F Mill Dean Clough   (United Kingdom)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

ⁱ LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; VANCOMYCIN;

ARTICLE; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; DISEASE COURSE; HOSPITAL DISCHARGE; HUMAN; ISOLATION PROCEDURE; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; MORBIDITY; PRIORITY JOURNAL; RESTRICTION MAPPING; TERTIARY HEALTH CARE;

BACTERIAL TYPING TECHNIQUES; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DEOXYRIBONUCLEASE HINDIII; DNA FINGERPRINTING; DNA, BACTERIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; EPIDEMIOLOGY, MOLECULAR; GENOTYPE; HUMANS; MINNESOTA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 70349918114     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/605638     Document Type: Article

References (21)

1. Fawley WN, Wilcox MH. Molecular epidemiology of endemic Clostridium difficile infection. Epidemiol Infect 2001; 126:343-350
2. O'Brien JA, Lahue BJ, Caro JJ, Davidson DM. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 2007;28:1219-1227
3. Cohen SC. Persistence of an endemic (toxigenic) isolate of Clostridium difficile in the environment of a general medicine ward. Clin Infect Dis 2000;30:952-954
4. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442-2449
5. McEllistrem MC, Carman RJ, Gerding DN, Genheimer CW, Zheng L. A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. Clin Infect Dis 2005; 40:265-272
6. Olson MM, Shanholtzer CJ, Lee JT, Gerding DN. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA medical center, 1982-1991. Infect Control Hosp Epidemiol 1994;15:371-381
7. Olson MM, Shanholzer CJ, Lee JT Jr, Gerding DN. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol 1995; 16:63-65
8. Gerding DN, Jensen B, Clabots CR, et al. Prevalence of asymptomatic carriage of three nosocomial pathogens prior to moving patients to a new hospital [abstract L4], In: Abstracts of the 89th Annual Meeting of the American Society for Microbiology (New Orleans). Washington, DC: American Society for Microbiology, 1989.
9. Shanholtzer CJ, Willard KE, Holter JJ, Olson MM, Gerding DN, Peterson LR. Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests. J Clin Microbiol 1992;30:1837-1840
10. Clabots C, Johnson S, Bettin K, et al. Development of a rapid and efficient restriction endonudease analysis (REA) typing system for Clostridium diffiale and correlation with other typing systems. J Clin Microbiol 1993;31:1870-1875.
11. Johnson S, Sambol SP, Brazier JS, et al. International typing study of toxin A-negative, B-positive Clostridium difficile variants. J Clin Microbiol 2003;41:1543-1547
12. Killgore G, Thompson A, Johnson S, et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: REA, PFGE, PCR-ribotyping, MLST, MLVA, AFLP, and slpAST. J Clin Microbiol 2008;46:431-437
13. McDonald LC, Killgore GE, Thompson A, et al. Emergence of an epidemic, toxin gene variant strain of Clostridium difficile responsible for outbreaks in the United States between 2000 and 2004. N Engl J Med 2005;353:2433-2441
14. Clabots C, Peterson LR, Gerding DN. Characterization of a nosocomial Clostridium difficile outbreak using plasmid profile typing and clindamycin susceptibility. J Infect Dis 1988; 158:731-736
15. Pear SM, Williamson TH, Bettin KM, Gerding DN, Galgiani JN. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med 1994;120:272-277
16. Climo MW, Israel DS, Wong ES, Williams D, Coudron P, Markowitz SM. Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost. Ann Intern Med 1998; 128:989-995
17. Johnson S, Samore MH, Farrow KA, et al. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med 1999;341:1645-1651
18. Samore MH, Bettin KM, DeGirolami PC, Clabots CR, Gerding DN, Karchmer AW. Wide diversity of Clostridium difficile types at a tertiary referral hospital. J Infect Dis 1994;170:615-621
19. Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992; 166:561-567
20. Johnson S, Clabots CR, Linn FV, Olson MM, Peterson LR, Gerding DN. Nosocomial Clostridium difficile colonization and disease. Lancet 1990;336:97-100.
21. Sawabe E, Kato H, Osawa K, et al. Molecular analysis of Clostridium difficile at a university teaching hospital in Japan: a shift in the predominant type over a five-year period. Eur J Clin Microbiol Infect Dis 2007;26:695-703. 1148-1152